Novel mechanisms contributing to cerebral vascular dysfunction during chronic hypertension

Current Hypertension Reports

Volumn 3, Issue 6, 2001, Pages 517-523

  Sobey, Christopher G ^a   Faraci, Frank M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASES; REACTIVE OXYGEN METABOLITE; RHO KINASE; RHO-ASSOCIATED KINASE;

BLOOD PRESSURE; BRAIN CIRCULATION; CHRONIC DISEASE; ENZYMOLOGY; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PHYSIOLOGY; POTASSIUM CHANNEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; CHRONIC DISEASE; HUMAN; HYPERTENSION; POTASSIUM CHANNELS; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; RENIN-ANGIOTENSIN SYSTEM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0035650889     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-001-0015-9     Document Type: Article

References (64)

1. Warlow CP: Epidemiology of stroke. Lancet 1998, 352(suppl III):1-4.
2. Faraci FM, Sobey CG: Role of potassium channels in regulation of cerebral vascular tone. J Cereb Blood Flow Metab 1998, 18:1047-1063.
3. Faraci FM, Heistad DD: Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 1998, 78:53-97.
4. Sobey CG: Potassium channel function in vascular disease. Arterioscler Thromb Vasc Biol 2001, 21: 28-38.
5. Nelson MT, Quayle JM: Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995, 268:C799-C822.
6. Sobey CG, Faraci FM: Effect of nitric oxide and potassium channel agonists and inhibitors on basilar artery diameter. Am J Physiol 1997, 272:H256-H262.
7. Paterno R, Heistad DD, Faraci FM: Functional activity of Ca2+-dependent K+ channels is increased in basilar artery during chronic hypertension. Am J Physiol 1997, 272:H1287-H1291.
8. Brenner R, Perez GJ, Bonev A.D., et al.: Vasoregulation by the b1 subunit of the calcium-activated potassium channel. Nature 2000, 407:870-876.
9. Pluger S, Faulhaber J, Furstenau M., et al.: Mice with disrupted BK channel b1 subunit gene feature abnormal Ca2+ spark/ STOC coupling and elevated blood pressure. Circ Res 2000, 87:e53-e60.
10. Asano M, Masuzawa-Ito K, Matsuda T., et al.: Functional role of Ca2+-activated K+ channels in resting state of carotid arteries from SHR. Am J Physiol 1993, 265:H843-H851.
11. Asano M, Masuzawa-Ito K, Matsuda T: Charybdotoxin-sensitive K+ channels regulate the myogenic tone in the resting state of arteries from spontaneously hypertensive rats. Br J Pharmacol 1993, 108:214-222.
12. Kolias TJ, Chai S, Webb RC: Potassium channel antagonists and vascular reactivity in stroke-prone spontaneously hypertensive rats. Am J Hypertens 1993, 6:528-533.
13. Liu Y, Hudetz AG, Knaus H-G, Rusch NJ: Increased expression of Ca2+-sensitive K+ channels in the cerebral microcirculation of genetically hypertensive rats. Evidence for their protection against cerebral vasospasm. Circ Res 1998, 82:729-737.
14. Didion SP, Sigmund CD, Faraci FM: Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen. Stroke 2000, 31:760-764, discussion 765.
15. Vanhoutte PM: Endothelial dysfunction in hypertension. J Hypertension 1996, 14(SUPPL. 5):S83-S93.
16. Mayhan WG, Faraci FM, Heistad DD: Impairment of endothelium-dependent responses of cerebral arterioles in chronic hypertension. Am J Physiol 1987, 253:H1435-H1440.
17. Mayhan WG, Faraci FM, Heistad DD: Responses of cerebral arterioles to adenosine 5'-diphophate, serotonin, and the thromboxane analogue U-46619 during chronic hypertension. Hypertension 1988, 12:556-561.
18. Hongo K, Nakagomi T, Kassel N.F., et al.: Effects of aging and hypertension on endothelium-dependent vascular relaxation in rat carotid artery. Stroke 1988, 19:892-897.
19. Lüscher T.F., Diederich D, Weber E., et al.: Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension 1988, 11:573-578.
20. White RM, Rivera CO, Davison CB: Differential contribution of endothelial function to vascular reactivity in conduit and resistance arteries from deoxycorticosterone-salt hypertensive rats. Hypertension 1996, 27:1245-1253.
21. Sobey CG, Moffatt JD, Cocks TM: Evidence for selective effects of chronic hypertension on cerebral artery vasodilatation to protease-activated receptor-2 activation. Stroke 1999, 30:1933-1941.
22. Chrissobolis S, Sobey CG: Evidence that rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: comparison with protein kinase C. Circ Res 2001, 88:774-779.
23. Mayhan WG: Role of prostaglandin H2-thromboxane A2 in responses of cerebral arterioles during chronic hypertension. Am J Physiol 1992, 262:H539-H543.
24. Taddei S, Virdis A, Mattei P., Salvetti A: Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993, 21: 929-933.
25. Taddei S, Virdis A, Ghiadoni L., et al.: Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 1997, 29:274-279.
26. Bennai F, Morsing P, Paliege A., et al.: Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats. J Am Soc Nephrol 1999, 10(SUPPL. 11):S104-S115.
27. Cosentino F, Sill JC, Katusic ZS: Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension 1994, 23:229-235.
28. Rosenblum WI: Effects of free radical generation on mouse pial arterioles: probable role of hydroxyl radicals. Am J Physiol 1983, 245:H139-H142.
29. Wei EP, Christman CW, Kontos H.A., Povlishock JT: Effects of oxygen radicals on cerebral arterioles. Am J Physiol 1985, 248:H157-H162.
30. Leffler CW, Busija DW, Armstead W.M., Mirro R: H2O2 effects on cerebral prostanoids and pial arteriolar diameter in piglets. Am J Physiol 1990, 258:H1382-H1387.
31. Wei EP, Kontos HA, Beckman JS: Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxynitrite. Am J Physiol 1996, 271:H1262-H1266.
32. Sobey CG, Heistad DD, Faraci FM: Mechanisms of bradykinin-induced cerebral vasodilatation in rats. Evidence that reactive oxygen species activate K+ channels. Stroke 1997, 28:2290-2295.
33. Sobey CG, Heistad DD, Faraci FM: Potassium channels mediate dilatation of cerebral arterioles in response to arachidonate. Am J Physiol 1998, 275:H1606-H1612.
34. Wei EP, Ellis EF, Kontos HA: Role of prostaglandins in pial arteriolar response to CO2 and hypoxia. Am J Physiol 1980, 238:H226-H230.
35. Busija DW, Heistad DD: Effects of indomethacin on cerebral blood flow during hypercapnia in cats. Am J Physiol 1983, 244:H519-H524.
36. Kontos HA, Wei EP, Povlishock J.T., Christman CW: Oxygen radicals mediate the cerebral arteriolar dilation from arachi-donate and bradykinin in cats. Circ Res 1984, 55:295-303.
37. Leffler CW, Busija DW: Arachidonate metabolism on the cerebral surface of newborn pigs. Prostaglandins 1985, 30:811-817.
38. Ellis EF, Police RJ, Yancey L, et al: Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol 1990, 259:H1171-H1177.
39. Iida Y, Katusic ZS: Mechanisms of cerebral arterial relaxations to hydrogen peroxide. Stroke 2000, 31: 2224-2230.
40. Didion SP, Faraci FM: Effects of NADH on cerebral blood vessels [abstract]. FASEBJ 2001, 15(4):A126.
41. Katusic ZS, Schugel J, Cosentino F., Vanhoutte PM: Endo-thelium-dependent contractions to oxygen-derived free radicals in the canine basilar artery. Am J Physiol 1993, 264:H859-H864.
42. Madden JA, Christman NJT: Integrin signaling, free radicals, and tyrosine kinase mediate flow constriction in isolated cerebral arteries. Am J Physiol 1999, 277:H2264-H2271.
43. Bryan RMJ J.r., Steenberg ML, Marelli SP: The role of endo-thelium in shear stress-induced constrictions in the rat middle cerebral artery. Stroke 2001, In press.
44. Didion SP, Hathaway CA, Faraci FM: Superoxide levels and function of cerebral blood vessels following inhibition of CuZn-SOD. Am J Physiol 2001, 281:H1697-H1703.
45. Somlyo AP, Somlyo AV: Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 2000, 522:177-185.
46. Osol G, Laher I, Cipolla M: Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res 1991, 68:359-367.
47. Osol G, Laher I, Kelley M: Myogenic tone is coupled to phospholipase C and G protein activation in small cerebral arteries. Am J Physiol 1993, 265:H415-H420.
48. Kimura K, Ito M, Amano M., et al.: Regulation of myosin phosphatase by rho and rho-associated kinase (rho-kinase). Science 1996, 273:245-248.
49. Akopov SE, Zhang L, Pearce WJ: Regulation of Ca2+ sensitization by PKC and rho proteins in ovine cerebral arteries: effects of artery size and age. Am J Physiol 1998, 275:H930-H939.
50. Hirata K, Kikuchi A, Sasaki T., et al.: Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem 1992, 267:8719-8722.
51. Uehata M, Ishizaki T, Satoh H., et al.: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389:990-994.
52. Kassell NF, Sasaki T, Colohan ART, Nazar G: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985, 16:562-572.
53. Macdonald RL, Weir BKA: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991, 22:971-982.
54. Cook DA: Mechanisms of cerebral vasospasm in subarachnoid haemorrhage. Pharmacol Ther 1995, 66:259-284.
55. Weir B: The pathophysiology of cerebral vasospasm. Br J Neurosurg 1995, 9:375-390.
56. Sobey CG, Faraci FM: Subarachnoid hæmorrhage: What happens to the cerebral arteries? Clin Exp Pharmacol Physiol 1998, 25:867-876.
57. Sato M, Tani E, Fujikawa H., Kaibuchi K: Involvement of rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 2000, 87:195-200.
58. Miyagi Y, Carpenter RC, Meguro T, et al: Upregulation of rho A and rho kinase messenger RNAs in the basilar artery of a rat model of subarachnoid hemorrhage. J Neurosurg 2000, 93:471-476.
59. Laufs U, Liao JK: Targeting rho in cardiovascular disease. Circ Res 2000, 87:526-528.
60. Packard CJ: Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study. Circulation 1998, 97:1440-1445.
61. Goldstein JL, Brown JS: Regulation of the mevalonate pathway. Nature 1990, 343:425-430.
62. Laufs U, Endres M, Stagliano N., et al.: Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest 2000, 106:15-24.
63. Laufs U, Gertz K, Huang P., et al.: Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 2000, 31:2442-2449.
64. Amin-Hanjani S., Stagliano NE, Yamada M, et al: Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 2001, 32:980-986.